STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Inovio Pharmaceuticals INO is preparing to release its quarterly earnings on Thursday, 2024-11-14. Here's a brief overview of ...

The core responsibility of regulatory affairs is to ensure products meet safety and quality standards from development to ...

These are the 300 companies whose success goes beyond profits to include employee and customer sentiment, cybersecurity, ...

Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

Mullein leaf and leaf extract have GRAS status by the FDA as there are no serious side-effects recorded so far. However, many ...

Cencora, Inc. (NYSE: COR) has announced the appointment of Francois Mandeville as Executive Vice President of Strategy and ...

GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage ...

Hyderabad: Telangana Fire Services Director General Y. Nagi Reddy emphasized the importance of conducting regular fire safety ...

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies ...